However, research on the role of carnitine in eye diseases is still in its preliminary stage, and more experimental and clinical studies are needed to explore its potential and mechanism in the treatment of eye diseases in depth
Nachnani JS, Bulchandani DG, Nookala A, Herndon B, Molteni A, Pandya P, Taylor R, Quinn T, Weide L, Alba LM
Are breastfeeding
The medication is administered via weekly subcutaneous self-injection, with dose titration starting at 0.25 mg weekly and increasing over sixteen to twenty weeks to the target dose of 2.4 mg weekly
The clinical information on day one was amazing, but day two dives even deeper, offering better applications and strategies to implement in my own practice